Pulse Oximetry Screening for Critical Congenital Heart Disease: A Four-Year Experience in Qatar
Authors:
Open Access
- 25 March 2026
- journal article
- Published by Springer Nature in Cureus
- Vol. 18 (3)
Abstract
Background: Critical congenital heart disease (CCHD) is a major cause of neonatal morbidity and mortality. Early postnatal detection using pulse oximetry screening (POCC) facilitates timely diagnosis and intervention.Keywords
This publication has 20 references indexed in Scilit:
- Impact of pulse oximetry screening to detect congenital heart defects: 5 years’ experience in a UK regional neonatal unitEuropean Journal of Pediatrics, 2021
- Pulse oximetry screening for critical congenital heart defectsCochrane Database of Systematic Reviews, 2018
- Association of US State Implementation of Newborn Screening Policies for Critical Congenital Heart Disease With Early Infant Cardiac DeathsJAMA, 2017
- Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective studyThe Lancet, 2014
- The impact of routine predischarge pulse oximetry screening in a regional neonatal unitArchives of Disease in Childhood - Fetal and Neonatal Edition, 2014
- Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysisThe Lancet, 2012
- Birth Prevalence of Congenital Heart Disease WorldwideJACC, 2011
- Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy studyThe Lancet, 2011
- Accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic reviewArchives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- The incidence of congenital heart diseaseJACC, 2002